Literature DB >> 6547171

Systemic hypertension in infants with bronchopulmonary dysplasia.

S H Abman, B A Warady, G M Lum, B L Koops.   

Abstract

Thirteen of 30 infants with bronchopulmonary dysplasia demonstrated systolic blood pressure readings above 113 mm Hg on at least three separate occasions. In contrast, only one of 22 infants without BPD developed hypertension. The onset of hypertension often followed discharge from the nursery, was transient, and responded well to antihypertensive medication. Its significance is exemplified by the presence of left ventricular hypertrophy in three infants and a cerebrovascular accident in one child. We conclude that systemic hypertension is a significant problem in infants with BPD, and recommend close monitoring of blood pressure during their follow-up care.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547171     DOI: 10.1016/s0022-3476(84)80501-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

3.  Short-duration hyperoxia causes genotoxicity in mouse lungs: protection by volatile anesthetic isoflurane.

Authors:  Venkatesh Kundumani-Sridharan; Jaganathan Subramani; Somasundaram Raghavan; Guru P Maiti; Cade Owens; Trevor Walker; John Wasnick; Steven Idell; Kumuda C Das
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

4.  A new look at bronchopulmonary dysplasia: postcapillary pathophysiology and cardiac dysfunction.

Authors:  Arvind Sehgal; Andra Malikiwi; Eldho Paul; Kenneth Tan; Samuel Menahem
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

5.  Systemic arterial stiffness in infants with bronchopulmonary dysplasia: potential cause of systemic hypertension.

Authors:  A Sehgal; A Malikiwi; E Paul; K Tan; S Menahem
Journal:  J Perinatol       Date:  2016-02-25       Impact factor: 2.521

6.  Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit.

Authors:  John M Dagle; Tyler J Fisher; Susan E Haynes; Susan K Berends; Patrick D Brophy; Frank H Morriss; Jeffrey C Murray
Journal:  J Pediatr       Date:  2011-02-24       Impact factor: 4.406

7.  Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Authors:  Wael A Seliem; Michael C Falk; Bruce Shadbolt; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

8.  Effect of chronic lung disease on blood pressure levels at follow up.

Authors:  A Greenough; E F Emery
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

9.  Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease.

Authors:  K Smets; P Vanhaesebrouck
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Dexamethasone and hypertension in preterm infants.

Authors:  A Greenough; E F Emery; H R Gamsu
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.